Leukemia, Lymphocytic, Chronic, B-Cell
Showing 1 - 25 of >10,000
Leukemia, Lymphocytic, Chronic, B-Cell Trial in New York (Zanubrutinib Pill, Venetoclax Pill, Obinutuzumab Injection)
Not yet recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- Zanubrutinib Pill
- +2 more
-
New York, New YorkWeill Cornell Medicine/NewYork-Presberteryian Hospital
Dec 6, 2022
ITGA4 Gene Methylation Status in Chronic Lymphocytic Leukemia
Not yet recruiting
- Chronic Lymphocytic Leukemia
- (no location specified)
May 7, 2022
Leukemia, Lymphocytic, Chronic, B-Cell Trial in Nanjing (JWCAR029 (Relmacabtagene Autoleucel))
Not yet recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- JWCAR029 (Relmacabtagene Autoleucel)
-
Nanjing, Jiangsu, ChinaJiangsu Province Hospital
Feb 17, 2022
Lymphoproliferative Disorders, Premalignant, Monoclonal B-Cell Lymphocytosis Trial (No intervention)
Not yet recruiting
- Lymphoproliferative Disorders
- +3 more
- No intervention
- (no location specified)
Jan 30, 2023
Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell Trial in Whittier (Pirtobrutinib, Ibrutinib)
Recruiting
- Chronic Lymphocytic Leukemia
- +3 more
-
Whittier, CaliforniaInnovative Clinical Research Institute
Aug 8, 2022
Chronic Lymphocytic Leukemia (CLL) Trial
Completed
- Chronic Lymphocytic Leukemia (CLL)
- (no location specified)
Apr 5, 2022
National Acalabrutinib Observational Study
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Non interventional study
- (no location specified)
Jun 27, 2022
B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine
Not yet recruiting
- B-cell Non Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Cyclophosphamide injection
- +2 more
-
Charleston, South CarolinaHollings Cancer Center at Medical University of South Carolina
Jan 18, 2023
Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance
Not yet recruiting
- Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
- (no location specified)
Dec 16, 2022
Chronic Lymphocytic Leukemia Trial in Madison ([U-13C]glucose, [13C5]glutamine)
Recruiting
- Chronic Lymphocytic Leukemia
- [U-13C]glucose
- [13C5]glutamine
-
Madison, WisconsinUniversity of Wisconsin
Jun 15, 2022
Indoleamine 2,3-dioxygenase Activity in Chronic Lymphocytic
Completed
- CLL
-
Tampere, FinlandTampere university Hospital
Feb 22, 2022
Small Lymphocytic Leukemia (SLL), Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI (Duvelisib, Ibrutinib)
Terminated
- Small Lymphocytic Leukemia (SLL)
- Chronic Lymphocytic Leukemia (CLL)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 15, 2022
Financial Difficulty in Patients With Blood Cancer
Recruiting
- Chronic Lymphocytic Leukemia
- Multiple Myeloma
-
Chapel Hill, North CarolinaUNC Medical Center
Aug 9, 2022
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Tampa (Fludarabine, Cyclophosphamide,
Recruiting
- Chronic Lymphocytic Leukemia
- +4 more
- Fludarabine
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 12, 2023
Venetoclax in Patients With Chronic Lymphocytic Leukemia
Recruiting
- Chronic Lymphocytic Leukemia
-
Taipei, TaiwanNational Taiwan University Hospital
Oct 27, 2021
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in New York (Ibrutinib, Pembrolizumab)
Recruiting
- Chronic Lymphocytic Leukemia
- Mantle Cell Lymphoma
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Aug 22, 2022
Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Ibrutinib 420 mg)
Not yet recruiting
- Autoimmune Hemolytic Anemia
- +3 more
- Ibrutinib 420 mg
- (no location specified)
Jan 12, 2023
CLL, Leukemia Trial in Houston (Eltrombopag)
Completed
- CLL
- Leukemia
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 14, 2022
Chronic Lymphocytic Leukemia Trial in Houston (Questionnaire Administration, Ruxolitinib Phosphate)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Questionnaire Administration
- Ruxolitinib Phosphate
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)
Active, not recruiting
- Chronic Lymphocytic Leukemia
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 23, 2022
Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
Recruiting
- Chronic Lymphocytic Leukemia
- +4 more
-
Bobigny, France
- +8 more
Mar 23, 2022
Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +5 more
- Ibrutinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 15, 2022
Chronic Lymphoid Leukemia in Relapse Trial in Tuebingen (Belimumab 200 MG/ML [Benlysta], standard of care)
Recruiting
- Chronic Lymphoid Leukemia in Relapse
- Belimumab 200 MG/ML [Benlysta]
- standard of care
-
Tuebingen, BW, GermanyUniversity Hospital Tuebingen, CCU Translational Immunology
Feb 2, 2022